Skip to main content

Table 1 TMA/aHUS scoring system

From: Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab

Score

Item

Point

TMA score (a)

Hb < 10.0 g/dLa

3

 

PLT < 150 × 109/L

3

 

Renal failureb

2

 

Extrarenal organ failuresc

2

 

Possible range

0 to 10

Positive aHUS score (b)d

Past history of TMA

1 time

1

  

 ≥ 2 times

3

 

Family history of TMA

1 family member

1

  

 ≥ 2 family member

3

 

Age at onset

 < 63 years

1

  

 < 10 years

3

 

Triggere

1

 

Possible range

0 to 10

Exclusion aHUS score (c)

Bloody stool

 − 3

 

ADAMTS13 < 10%

 − 3

 

Underlying diseasesf

 − 3

 

D-dimerg > 20 μg/mL

 − 3

 

WBCh > 16,000/mL

 − 3

 

Possible range

 − 15 to 0

TMA/aHUS score

 = a + b + c

 − 15 to 20

  1. aDescription used in post-marketing surveillance: microangiopathic hemolytic anemia (defined from following items: Hb < 10 g/dL, LDH increase, haptoglobin decrease, presence of schistocyte)
  2. bDescription used in post-marketing surveillance: acute kidney injury (adults: satisfied diagnostic criteria for acute kidney injury; pediatrics: sCr ≥ 1.5 × age-appropriate ULN)
  3. cTwo points were given if any of the following applied: neuropsychiatric symptoms, gastrointestinal symptoms, others (thromboembolism, angina pectoris, dyspnea, others) except for fever
  4. dRed or brownish urine from the original scoring system was deleted
  5. eOne point was given for any of the following: viral infection (excluding pneumococcal infection), pregnancy, renal transplantation, or autoimmune and connective tissue diseases
  6. fThree points were excluded if any of the following applied: malignant tumor, hematopoietic stem-cell transplantation, chemotherapy acute pancreatitis, or bacterial infection
  7. gModified from fibrin/fibrinogen degradation products (FDP) in the original scoring system
  8. hModified from C-reactive protein (CRP) in the original scoring system
  9. Abbreviations: ADAMTS13 a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13, aHUS atypical hemolytic uremic syndrome, Hb hemoglobin, PLT platelet count, sCr serum creatinine, TMA thrombotic microangiopathy, ULN upper limit of normal, WBC white blood cell count